166 related articles for article (PubMed ID: 31038497)
21. Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug.
Li D; Huang X; Wu Y; Li J; Cheng W; He J; Tian H; Huang Y
Biomater Sci; 2016 Feb; 4(2):272-80. PubMed ID: 26484364
[TBL] [Abstract][Full Text] [Related]
22. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.
Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J
Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254
[TBL] [Abstract][Full Text] [Related]
23. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z
Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801
[TBL] [Abstract][Full Text] [Related]
24. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
[TBL] [Abstract][Full Text] [Related]
25. Ultra-small BaGdF5-based upconversion nanoparticles as drug carriers and multimodal imaging probes.
Yang D; Dai Y; Liu J; Zhou Y; Chen Y; Li C; Ma P; Lin J
Biomaterials; 2014 Feb; 35(6):2011-23. PubMed ID: 24314558
[TBL] [Abstract][Full Text] [Related]
26. Near-infrared light-mediated DOX-UCNPs@mHTiO
Chen Y; Lin H; Tong R; An N; Qu F
Colloids Surf B Biointerfaces; 2017 Jun; 154():429-437. PubMed ID: 28391106
[TBL] [Abstract][Full Text] [Related]
27. Fabrication of biodegradable auto-fluorescent organosilica nanoparticles with dendritic mesoporous structures for pH/redox-responsive drug release.
Li X; Chen Y; Zhang X; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110914. PubMed ID: 32409066
[TBL] [Abstract][Full Text] [Related]
28. AIE/FRET-based versatile PEG-Pep-TPE/DOX nanoparticles for cancer therapy and real-time drug release monitoring.
Wang TT; Wei QC; Zhang ZT; Lin MT; Chen JJ; Zhou Y; Guo NN; Zhong XC; Xu WH; Liu ZX; Han M; Gao JQ
Biomater Sci; 2020 Jan; 8(1):118-124. PubMed ID: 31777865
[TBL] [Abstract][Full Text] [Related]
29. Combinatory Cancer Therapeutics with Nanoceria-Capped Mesoporous Silica Nanocarriers through pH-triggered Drug Release and Redox Activity.
Singh RK; Patel KD; Mahapatra C; Parthiban SP; Kim TH; Kim HW
ACS Appl Mater Interfaces; 2019 Jan; 11(1):288-299. PubMed ID: 30539634
[TBL] [Abstract][Full Text] [Related]
30. Doxorubicin conjugated NaYF(4):Yb(3+)/Tm(3+) nanoparticles for therapy and sensing of drug delivery by luminescence resonance energy transfer.
Dai Y; Yang D; Ma P; Kang X; Zhang X; Li C; Hou Z; Cheng Z; Lin J
Biomaterials; 2012 Nov; 33(33):8704-13. PubMed ID: 22938822
[TBL] [Abstract][Full Text] [Related]
31. Intracellular Dynamic Disentangling of Doxorubicin Release from Luminescent Nanogold Carriers by Fluorescence Lifetime Imaging Microscopy (FLIM) under Two-Photon Excitation.
Suarasan S; Craciun AM; Licarete E; Focsan M; Magyari K; Astilean S
ACS Appl Mater Interfaces; 2019 Feb; 11(8):7812-7822. PubMed ID: 30707545
[TBL] [Abstract][Full Text] [Related]
32. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
33. A targeted drug delivery system based on folic acid-functionalized upconversion luminescent nanoparticles.
Liang X; Fan J; Zhao Y; Cheng M; Wang X; Jin R; Sun T
J Biomater Appl; 2017 Apr; 31(9):1247-1256. PubMed ID: 28350205
[TBL] [Abstract][Full Text] [Related]
34. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
35. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
36. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
37. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy.
Wang C; Cheng L; Liu Z
Biomaterials; 2011 Feb; 32(4):1110-20. PubMed ID: 20965564
[TBL] [Abstract][Full Text] [Related]
38. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
Kashyap S; Singh N; Surnar B; Jayakannan M
Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
[TBL] [Abstract][Full Text] [Related]
39. Dual Stimuli-Responsive Nanoparticles for Controlled Release of Anticancer and Anti-inflammatory Drugs Combination.
Feng L; Wang Y; Luo Z; Huang Z; Zhang Y; Guo K; Ye D
Chemistry; 2017 Jul; 23(39):9397-9406. PubMed ID: 28489292
[TBL] [Abstract][Full Text] [Related]
40. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.
Li J; Du X; Zheng N; Xu L; Xu J; Li S
Colloids Surf B Biointerfaces; 2016 May; 141():374-381. PubMed ID: 26878288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
